Frank Scherbaum

Frank Scherbaum has had a diverse work experience spanning several industries and roles. Currently, they are working as the Head of Market Access GSA at Insulet International since January 2021. Prior to that, they owned their own company, Oxington GmbH, starting from January 2016. From January 2019 to December 2020, Frank worked as the Group Leader of Health Economics and Reimbursement Europe at Olympus Europa SE & Co. KG.

Frank Scherbaum attended Kaufmännisches Berufskolleg Walther Rathenau where they studied Internationale Beziehungen und Angelegenheiten. Frank did not obtain a degree from this institution. In 1993-1994, they engaged in an unspecified educational pursuit. Frank also studied at Walther Rathenau, but the details of this education are not provided. Additionally, Frank Scherbaum has obtained several certifications, including Data Science for Business from Harvard Business School Online in 2023, Antragsverfahren Hilfsmittelverzeichnis from BVMed-Akademie in 2022, Vernetzte Medizingeräte und Security from BVMed-Akademie in 2022, and Health Software: Wie kommt die Medical Software auf den Markt? from VDE in 2020.